Mou Li1, Ling Yang1, Yufeng Yue1, Jingxu Xu2, Chencui Huang2, Bin Song1. 1. Department of Radiology, West China Hospital of Sichuan University, Chengdu, China. 2. Department of Research Collaboration, R&D Center, Beijing Deepwise & League of PHD Technology Co., Ltd, Beijing, China.
Abstract
OBJECTIVE: To investigate whether a radiomics model can help to improve the performance of PI-RADS v2.1 in prostate cancer (PCa). METHODS: This was a retrospective analysis of 203 patients with pathologically confirmed PCa or non-PCa between March 2015 and December 2016. Patients were divided into a training set (n = 141) and a validation set (n = 62). The radiomics model (Rad-score) was developed based on multi-parametric MRI including T2 weighted imaging (T2WI), diffusion weighted imaging (DWI), apparent diffusion coefficient (ADC) imaging, and dynamic contrast enhanced (DCE) imaging. The combined model involving Rad-score and PI-RADS was compared with PI-RADS for the diagnosis of PCa by using the receiver operating characteristic curve (ROC) analysis. RESULTS: A total of 112 (55.2%) patients had PCa, and 91 (44.8%) patients had benign lesions. For PCa versus non-PCa, the Rad-score had a significantly higher area under the ROC curve (AUC) [0.979 (95% CI, 0.940-0.996)] than PI-RADS [0.905 (0.844-0.948), P = 0.002] in the training set. However, the AUC between them was insignificant in the validation set [0.861 (0.749-0.936) vs. 0.845 (0.731-0.924), P = 0.825]. When Rad-score was added to PI-RADS, the performance of the PI-RADS was significantly improved for the PCa diagnosis (AUC = 0.989, P < 0.001 for the training set and AUC = 0.931, P = 0.038 for the validation set). CONCLUSIONS: The radiomics based on multi-parametric MRI can help to improve the diagnostic performance of PI-RADS v2.1 in PCa.
OBJECTIVE: To investigate whether a radiomics model can help to improve the performance of PI-RADS v2.1 in prostate cancer (PCa). METHODS: This was a retrospective analysis of 203 patients with pathologically confirmed PCa or non-PCa between March 2015 and December 2016. Patients were divided into a training set (n = 141) and a validation set (n = 62). The radiomics model (Rad-score) was developed based on multi-parametric MRI including T2 weighted imaging (T2WI), diffusion weighted imaging (DWI), apparent diffusion coefficient (ADC) imaging, and dynamic contrast enhanced (DCE) imaging. The combined model involving Rad-score and PI-RADS was compared with PI-RADS for the diagnosis of PCa by using the receiver operating characteristic curve (ROC) analysis. RESULTS: A total of 112 (55.2%) patients had PCa, and 91 (44.8%) patients had benign lesions. For PCa versus non-PCa, the Rad-score had a significantly higher area under the ROC curve (AUC) [0.979 (95% CI, 0.940-0.996)] than PI-RADS [0.905 (0.844-0.948), P = 0.002] in the training set. However, the AUC between them was insignificant in the validation set [0.861 (0.749-0.936) vs. 0.845 (0.731-0.924), P = 0.825]. When Rad-score was added to PI-RADS, the performance of the PI-RADS was significantly improved for the PCa diagnosis (AUC = 0.989, P < 0.001 for the training set and AUC = 0.931, P = 0.038 for the validation set). CONCLUSIONS: The radiomics based on multi-parametric MRI can help to improve the diagnostic performance of PI-RADS v2.1 in PCa.
Authors: Andrew B Rosenkrantz; Luke A Ginocchio; Daniel Cornfeld; Adam T Froemming; Rajan T Gupta; Baris Turkbey; Antonio C Westphalen; James S Babb; Daniel J Margolis Journal: Radiology Date: 2016-04-01 Impact factor: 11.105
Authors: Marc A Bjurlin; Peter R Carroll; Scott Eggener; Pat F Fulgham; Daniel J Margolis; Peter A Pinto; Andrew B Rosenkrantz; Jonathan N Rubenstein; Daniel B Rukstalis; Samir S Taneja; Baris Turkbey Journal: J Urol Date: 2019-10-23 Impact factor: 7.450
Authors: Teodora Telecan; Iulia Andras; Nicolae Crisan; Lorin Giurgiu; Emanuel Darius Căta; Cosmin Caraiani; Andrei Lebovici; Bianca Boca; Zoltan Balint; Laura Diosan; Monica Lupsor-Platon Journal: J Pers Med Date: 2022-06-16
Authors: Chidozie N Ogbonnaya; Xinyu Zhang; Basim S O Alsaedi; Norman Pratt; Yilong Zhang; Lisa Johnston; Ghulam Nabi Journal: Cancers (Basel) Date: 2021-12-09 Impact factor: 6.639